Corcept Therapeutics up 26% on new Korlym patent [Seeking Alpha]
Corcept Therapeutics Incorporated (CORT)
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corcept.com/investors
Company Research
Source: Seeking Alpha
Corcept Therapeutics ( CORT ) is up on almost a 5x surge in volume in response to a reported new U.S. patent covering Korlym (mifepristone). The investors are reacting bullishly since a new patent strengthens its position against would-be generic competitors, including Teva Pharmaceutical Industries ( TEVA ), who has already filed an ANDA and is challenging the validity of two other U.S. patents covering the cortisol receptor blocker. Korlym currently accounts for all of Corcept's sales. Source: Bloomberg See all stocks on the move » Now read: Big Insider Buying In Iovance Biotherapeutics » Subscribe for full text news in your inbox
Show less
Read more
Impact Snapshot
Event Time:
CORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CORT alerts
High impacting Corcept Therapeutics Incorporated news events
Weekly update
A roundup of the hottest topics
CORT
News
- Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Corcept Therapeutics: Key Catalysts Ahead [Seeking Alpha]Seeking Alpha
- Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow [Yahoo! Finance]Yahoo! Finance
CORT
Earnings
- 2/15/24 - Beat
CORT
Sec Filings
- 3/27/24 - Form SC
- 3/27/24 - Form 144
- 3/20/24 - Form 4
- CORT's page on the SEC website